OpGen (OPGN)
(Delayed Data from NSDQ)
$2.64 USD
-0.06 (-2.23%)
Updated Jun 7, 2024 03:39 PM ET
After-Market: $2.63 -0.01 (-0.38%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Income Statements
Fiscal Year end for OpGen, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 3 | 3 | 4 | 4 | 4 |
Cost Of Goods | 4 | 3 | 3 | 4 | 2 |
Gross Profit | 0 | -1 | 1 | 0 | 2 |
Selling & Adminstrative & Depr. & Amort Expenses | 31 | 34 | 25 | 23 | 14 |
Income After Depreciation & Amortization | -31 | -35 | -23 | -23 | -12 |
Non-Operating Income | 0 | 1 | -7 | 0 | 0 |
Interest Expense | 2 | 3 | 5 | 3 | 0 |
Pretax Income | -33 | -37 | -35 | -26 | -12 |
Income Taxes | NA | 0 | 0 | 0 | 0 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -33 | -37 | -35 | -26 | -12 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -33 | -37 | -35 | -26 | -12 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -29 | -33 | -21 | -20 | -11 |
Depreciation & Amortization (Cash Flow) | 1 | 2 | 3 | 2 | 1 |
Income After Depreciation & Amortization | -31 | -35 | -23 | -23 | -12 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | NA | 0.24 | 0.18 | 0.08 | 0.01 |
Diluted EPS Before Non-Recurring Items | -99,999.00 | -102.10 | -186.00 | -322.00 | -1,380.00 |
Diluted Net EPS (GAAP) | -41.47 | -152.70 | -228.00 | -332.00 | -1,540.00 |
Fiscal Year end for OpGen, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 1.07 | 0.70 | 0.74 | 0.91 |
Cost Of Goods | NA | 1.18 | 0.69 | 0.92 | 0.72 |
Gross Profit | NA | -0.11 | 0.01 | -0.18 | 0.19 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1.79 | 3.57 | 4.98 | 5.26 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -1.90 | -3.56 | -5.16 | -5.07 |
Non-Operating Income | NA | 0.06 | -0.10 | 0.01 | -0.05 |
Interest Expense | NA | 0.14 | 0.40 | 0.68 | 0.62 |
Pretax Income | NA | -17.04 | -4.06 | -5.83 | -5.74 |
Income Taxes | NA | NA | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | NA | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | NA | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | NA | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -17.04 | -4.06 | -5.83 | -5.74 |
Extras & Discontinued Operations | NA | NA | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -17.04 | -4.06 | -5.83 | -5.74 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | 0.88 | 0.63 | 0.46 |
Diluted EPS Before Non-Recurring Items | -99,999.00 | -99,999.00 | -4.60 | -9.30 | -12.50 |
Diluted Net EPS (GAAP) | -99,999.00 | -15.07 | -4.60 | -9.30 | -12.50 |